These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11351375)

  • 1. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer.
    Fry A; Busby-Earle C; Rush R; Cull A
    Psychooncology; 2001; 10(3):231-41. PubMed ID: 11351375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy.
    Tucker PE; Bulsara MK; Salfinger SG; Tan JJ; Green H; Cohen PA
    Maturitas; 2016 Mar; 85():42-8. PubMed ID: 26857878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.
    Elit L; Esplen MJ; Butler K; Narod S
    Fam Cancer; 2001; 1(3-4):149-56. PubMed ID: 14574171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual function, menopausal symptoms, depression and cancer worry in women with BRCA mutations.
    Powell CB; Alabaster A; Le A; Stoller N; Armstrong MA; Raine-Bennett T
    Psychooncology; 2020 Feb; 29(2):331-338. PubMed ID: 31654466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.
    Fang CY; Cherry C; Devarajan K; Li T; Malick J; Daly MB
    Gynecol Oncol; 2009 Mar; 112(3):594-600. PubMed ID: 19141360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of prophylactic oophorectomy on mood and sexual function in women of menopausal transition or postmenopausal period.
    Chen X; Guo T; Li B
    Arch Gynecol Obstet; 2013 Nov; 288(5):1101-6. PubMed ID: 23625334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.
    Aziz A; Bergquist C; Brännström M; Nordholm L; Silfverstolpe G
    Acta Obstet Gynecol Scand; 2005 Sep; 84(9):854-9. PubMed ID: 16097975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy.
    Johansen N; Liavaag AH; Tanbo TG; Dahl AA; Pripp AH; Michelsen TM
    Gynecol Oncol; 2016 Jan; 140(1):101-6. PubMed ID: 26597462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.
    Finch A; Metcalfe KA; Chiang J; Elit L; McLaughlin J; Springate C; Esplen MJ; Demsky R; Murphy J; Rosen B; Narod SA
    Psychooncology; 2013 Jan; 22(1):212-9. PubMed ID: 21913283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.
    Tiller K; Meiser B; Butow P; Clifton M; Thewes B; Friedlander M; Tucker K
    Gynecol Oncol; 2002 Aug; 86(2):212-9. PubMed ID: 12144830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report.
    Shigehiro M; Kita M; Takeuchi S; Ashihara Y; Arai M; Okamura H
    Jpn J Clin Oncol; 2016 Mar; 46(3):254-9. PubMed ID: 26685323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer.
    Meiser B; Tiller K; Gleeson MA; Andrews L; Robertson G; Tucker KM
    Psychooncology; 2000; 9(6):496-503. PubMed ID: 11180584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
    Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
    Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.
    Vermeulen RFM; Beurden MV; Kieffer JM; Bleiker EMA; Valdimarsdottir HB; Massuger LFAG; Mourits MJE; Gaarenstroom KN; van Dorst EBL; van der Putten HWHM; Aaronson NK
    Eur J Cancer; 2017 Oct; 84():159-167. PubMed ID: 28818705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.
    Hallowell N
    Psychooncology; 2000; 9(6):486-95. PubMed ID: 11180583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
    Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
    N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by fellows and members of the Royal College of Obstetricians and Gynaecologists.
    Jacobs I; Oram D
    Br J Obstet Gynaecol; 1989 May; 96(5):510-5. PubMed ID: 2757978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
    Swisher EM; Babb S; Whelan A; Mutch DG; Rader JS
    J Reprod Med; 2001 Feb; 46(2):87-94. PubMed ID: 11255821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.